|
H100 Hemoglobin Analyzer (HbA1c HPLC System) – High-Precision Diabetes & Thalassemia Testing
As Chinese manufacturers push toward higher-margin diagnostic instruments, the H100 represents a strategic convergence of two high-volume testing markets—glycated hemoglobin and hemoglobinopathy screening—in a single HPLC platform.
The H100 Hemoglobin Analyzer is a fully automated HPLC system that runs both HbA1c and β-thalassemia tests. At 96 seconds per HbA1c result and 350 seconds for thalassemia, it is built for continuous batch processing in medium-to-high throughput clinical labs.
Its one-click mode switching eliminates a major operational friction: labs previously needed separate instruments or manual column changes for each assay. The 50- or 110-position sample loader, combined with automated inversion mixing and a single STAT slot, allows uninterrupted runs with minimal technician intervention.
The V-win reporting software automatically flags abnormal hemoglobin variants—an important feature in regions where thalassemia is endemic. NGSP and IFCC certification ensures the HbA1c results align with international standardization protocols, a requirement for diabetes management programs.
From a procurement perspective, the H100 consolidates two testing workflows into one capital purchase. For hospital networks in Southeast Asia, the Middle East, and southern China—where both diabetes and thalassemia are prevalent—this reduces equipment footprint and per-test overhead.
The unit’s 10.1-inch Linux-based interface and 20,000-result onboard storage point to a broader trend: Chinese diagnostics manufacturers are matching user interface expectations of global incumbents while keeping hardware costs competitive. The H100 does not require proprietary reagents, giving labs leverage in consumables sourcing.
A single machine that routinely handles two high-prevalence chronic conditions is a more resilient investment for off-grid or regional labs than a dedicated single-assay system.
Why it matters:
For labs managing both diabetes and thalassemia caseloads, the H100 replaces two instruments with one, reducing training time, maintenance overhead, and per-test cost. Its dual-mode HPLC design offers a practical path for resource-constrained facilities to upgrade diagnostic coverage without expanding physical footprint.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
|
|
No products in the cart.